This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and ...

Advanced technologies and close collaboration maximize yields, safety, and patient access to life-saving therapies.

Looking at key trends in outsourcing, manufacturing, and regulatory compliance. Embracing innovation, flexibility, and talent ...

How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based ...

BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...